Skip to content

Prostatitis

BASICS

  • Definition: Painful or inflammatory condition of the prostate; may or may not be bacterial. Characterized by urogenital pain, voiding symptoms, and/or sexual dysfunction.
  • NIH Classifications:
  • Class I: Acute bacterial prostatitis—fever, perineal pain, dysuria, obstructive symptoms; PMNL & bacteria in urine
  • Class II: Chronic bacterial prostatitis—chronic or recurrent infection; pain and voiding issues; PMNL & bacteria in EPS, post-massage urine, or semen
  • Class III: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
    • IIIA: Inflammatory (PMNL in EPS/urine after massage/semen)
    • IIIB: Noninflammatory (no PMNL in EPS/urine/semen)
  • Class IV: Asymptomatic inflammatory prostatitis—incidental, no symptoms; PMNL/bacteria in EPS/urine/semen

EPIDEMIOLOGY

  • Incidence: 2 million US cases/year; bimodal (20–40 and >60 yrs)
  • Prevalence: Affects ~16% of men
  • Accounts for: 8% of urologist visits, 1% of primary care visits
  • More common in HIV patients, post-age 50, after prostate procedures

ETIOLOGY & PATHOPHYSIOLOGY

  • Acute bacterial (Class I): Ascending urethral infection (E. coli most common), often after instrumentation; rarely Staph aureus (evaluate for hematogenous source)
  • Chronic bacterial (Class II): Same pathogens; recurrent
  • CP/CPPS (Class III): Unclear; possible inflammation or neuromuscular pain, no clear histologic correlation
  • Consider: STI pathogens (N. gonorrhoeae, C. trachomatis) in men <35 yrs

RISK FACTORS

  • UTI/STI
  • HIV
  • Prostatic calculi
  • Catheterization, GU instrumentation (biopsy, TURP)
  • Urinary retention, BPH
  • Unprotected sex
  • Prostate cancer

PREVENTION

  • Antibiotic prophylaxis for GU procedures/biopsy
  • Physical activity reduces CP/CPPS risk

ASSOCIATED CONDITIONS

  • BPH, cystitis, urethritis
  • Sexual dysfunction (ED, premature ejaculation)

DIAGNOSIS

History

  • Acute: Fever, chills, malaise, low back/pelvic/perineal pain, dysuria, urgency, retention, cloudy urine
  • Chronic: Insidious, >3 months, pelvic/prostatic/perineal pain, dysuria, low-grade fever, hematospermia, sexual dysfunction

Physical Exam

  • Vital signs (instability suggests sepsis)
  • Abdominal: Bladder distention, CVA tenderness
  • Prostate exam:
  • Acute: Tender, warm, firm, edematous (AVOID vigorous massage—may cause bacteremia)
  • Chronic/CPPS: Often normal, occasionally enlarged/tender

Differential Diagnosis

  • UTI, pyelonephritis, cystitis, urethritis, epididymitis, proctitis, prostatic abscess, BPH/cancer, stones

Tests

  • Acute: UA, urine C&S, CBC, blood cultures (if sepsis suspected), STI testing (<35 yrs/high risk)
  • Imaging: Only if abscess or complication suspected (TRUS/CT)
  • Chronic: Pre/post-prostatic massage urine cultures (optional), urodynamics (optional)
  • CP/CPPS: Diagnosis of exclusion; NIH-CPSI questionnaire for symptoms

TREATMENT

General Measures

  • NSAIDs, α1-blockers (for LUTS), antipyretics, sitz baths, hydration, stool softeners, urinary drainage if retention

Medications

  • Acute bacterial (Class I, outpatient):
  • Fluoroquinolones (ciprofloxacin or levofloxacin)
  • Trimethoprim-sulfamethoxazole (if low local resistance)
  • If STI risk: ceftriaxone/cefixime + doxycycline
  • Duration: 2–4 weeks (may extend to 4–6 weeks)
  • Acute bacterial (Class I, inpatient):
  • Urinary drainage
  • Broad-spectrum IV antibiotics (ceftriaxone, levofloxacin, Zosyn, +/- aminoglycoside)
  • De-escalate to oral when improved; total duration 2–4 weeks
  • Chronic bacterial (Class II):
  • Fluoroquinolones or TMP-SMX for 4–12 weeks
  • If Enterococcus: moxifloxacin or linezolid
  • α1-blockers + antibiotics reduce recurrence
  • CP/CPPS (Class III):
  • Empiric trial: Caffeine/alcohol avoidance, α1-blockers, NSAIDs, possibly fluoroquinolones

REFERRAL

  • Urology: Failure of antibiotics, persistent symptoms, obstructive LUTS, hematuria, elevated PSA, prostatic abscess
  • Surgical: Drain abscess, refractory chronic cases

OTHER THERAPIES

  • CBT for psychosocial/sexual dysfunction
  • Pudendal nerve block/neurolysis for nerve entrapment

SURGERY

  • Resection for refractory recurrent bacterial prostatitis or abscess

INPATIENT INDICATIONS

  • Sepsis, urinary retention, PO intolerance, prostatic abscess, immunocompromised

FOLLOW-UP

  • Acute: Negative urine culture at day 7 = good prognosis
  • Chronic: Often prolonged; 10% progress from acute to chronic

PROGNOSIS

  • Acute: Fever/dysuria resolve in 2–6 days, usually improved by 3–4 weeks
  • Chronic: 55–97% cure depending on regimen, but 20% may have reinfection/persistent infection

COMPLICATIONS

  • Prostatic abscess (esp. HIV)
  • Pyelonephritis, urinary retention, epididymitis, infertility, metastatic infection, ED

ICD-10 CODES

  • N41.8 Other inflammatory diseases of prostate
  • N41 Inflammatory diseases of prostate
  • N41.4 Granulomatous prostatitis

CLINICAL PEARLS

  • Prostatic massage contraindicated in acute prostatitis
  • Fluoroquinolones = first-line for bacterial prostatitis
  • Acute: 14–30 days antibiotics; chronic: longer